Biocept, Inc.
(NASDAQ : BIOC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.47%91.121.3%$816.71m
AMGNAmgen Inc.
0.82%188.501.2%$645.74m
GILDGilead Sciences, Inc.
0.61%67.170.9%$519.20m
BIIBBiogen Inc.
0.47%334.551.3%$453.63m
ILMNIllumina, Inc.
-0.73%300.043.5%$321.58m
REGNRegeneron Pharmaceuticals, Inc.
0.32%421.942.6%$311.62m
VRTXVertex Pharmaceuticals Incorporated
0.73%188.231.9%$273.67m
ALXNAlexion Pharmaceuticals, Inc.
0.72%129.862.0%$237.24m
SRPTSarepta Therapeutics, Inc.
1.16%141.8815.4%$160.12m
AAgilent Technologies, Inc.
0.72%78.081.6%$143.42m
EXASExact Sciences Corporation
-2.42%83.5025.3%$127.48m
INCYIncyte Corporation
-0.62%83.562.5%$115.83m
ARRYArray BioPharma Inc.
0.67%23.268.2%$111.24m
EXELExelixis, Inc.
-0.16%21.326.4%$84.40m
NBIXNeurocrine Biosciences, Inc.
-0.24%80.705.1%$82.45m

Company Profile

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.